Ibrutinib (PCI-32765), the First BTK (Bruton’s Tyrosine Kinase) Inhibitor in Clinical Trials Jennifer R. Brown Chronic Leukemias (S O’Brien, Section Editor) 08 January 2013 Pages: 1 - 6
Lenalidomide Alone and in Combination for Chronic Lymphocytic Leukemia Christine I. Chen Chronic Leukemias (S O’Brien, Section Editor) 20 December 2012 Pages: 7 - 13
Targeting Chronic Myeloid Leukemia Stem Cells Ross KinstrieMhairi Copland Chronic Leukemias (J Goldman, Section Editor) 20 December 2012 Pages: 14 - 21
GS-1101: A Delta-Specific PI3K Inhibitor in Chronic Lymphocytic Leukemia Ines M. Macias-PerezIan W. Flinn Chronic Leukemias (S O’Brien, Section Editor) 02 November 2012 Pages: 22 - 27
Role of Epigenetics in Chronic Myeloid Leukemia Katerina Machova PolakovaJitka KoblihovaTomas Stopka Chronic Leukemias (J Goldman, Section Editor) Open access 08 January 2013 Pages: 28 - 36
Management of the New Patient with CML in Chronic Phase David Marin Chronic Leukemias (J Goldman, Section Editor) 05 February 2013 Pages: 37 - 42
Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia Jiří PavlůJane F. Apperley Chronic Leukemias (J Goldman, Section Editor) 29 December 2012 Pages: 43 - 51
Monoclonal B Cell Lymphocytosis—What Does It Really Mean? Andy C. Rawstron Chronic Leukemias (S O’Brien, Section Editor) 11 January 2013 Pages: 52 - 59
CARs in Chronic Lymphocytic Leukemia – Ready to Drive Chitra HosingPartow KebriaeiElizabeth Shpall Chronic Leukemias (S O’Brien, Section Editor) 09 December 2012 Pages: 60 - 70
Signal Transduction in the Chronic Leukemias: Implications for Targeted Therapies Wesam AhmedRichard A. Van Etten CHRONIC LEUKEMIAS (J GOLDMAN, SECTION EDITOR) 10 January 2013 Pages: 71 - 80
What Do We Do with Chronic Lymphocytic Leukemia with 17p Deletion? L. SellnerS. DenzingerT. Zenz Chronic Leukemias (S O’Brien, Section Editor) 28 November 2012 Pages: 81 - 90